Inventor · disambiguated record
Christine Menetrier-Caux
Also filed as: MENETRIER-CAUX CHRISTINE
9 granted patents·3 pending applications·74 citations·filing 2010–2020
87Inventor score
Files withINST NAT SANTE RECH MED5INSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)2CAUX CHRISTOPHE1CENTRE LEON BERARD1FAGET JULIEN1
Top patents by PatentIndex Score
12 records- 0193US9376493B2Antibodies directed against ICOS and uses thereofFAGET JULIEN·Filed 2012·Granted Jun 28, 2016·48 cites·4 claims
- 0290US9676852B2Antibodies directed against ICOS and uses thereofINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2016·Granted Jun 13, 2017·8 cites·17 claims
- 0389US11180556B2Antibodies directed against ICOS and uses thereofINST NAT SANTE RECH MED·Filed 2018·Granted Nov 23, 2021·2 cites·8 claims
- 0489US10745482B2Antibodies directed against ICOS and uses thereofINSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2019·Granted Aug 18, 2020·2 cites·7 claims
- 0588US9975950B2Antibodies directed against ICOS and uses thereofINST NAT SANTE RECH MED·Filed 2017·Granted May 22, 2018·5 cites·17 claims
- 0684US10633446B2Antibodies directed against ICOS and uses thereofINST NAT SANTE RECH MED·Filed 2019·Granted Apr 28, 2020·1 cites·20 claims
- 0783US11130817B2CD73 blocking agentsINNATE PHARMA·Filed 2016·Granted Sep 28, 2021·3 cites·5 claims
- 0883US9695247B2Antibodies directed against ICOS for treating graft-versus-host diseaseINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2013·Granted Jul 4, 2017·5 cites·6 claims
- 0973US2020347134A1Antibodies Directed Against ICOS and Uses ThereofINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 1057US10273306B2Antibodies directed against ICOS for treating graft-versus-host diseaseINST NAT SANTE RECH MED·Filed 2017·Granted Apr 30, 2019·0 cites·4 claims
- 1138US2020232974A1Lymphocytes expressing cd73 in cancerous patient dictates therapyCENTRE LEON BERARD·Filed 2017·Application pending·0 cites
- 1238US2012309013A1Use of the Combinatorial Diversity of T-Lymphocyte Repertoire as a Prognostic Marker of CancerCAUX CHRISTOPHE·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christine Menetrier-Caux files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →